Loading news...
Not all REITs are worth buying. In fact, some of them are facing severe difficulties. I highlight which REITs to avoid going into 2026.
Commonwealth Equity Services LLC lessened its position in shares of American Healthcare REIT, Inc. (NYSE: AHR) by 19.2% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 934,276 shares of the company's stock after selling 221,901 shares during the quarter. Commonwealth Equity
IRVINE, Calif., Jan. 6, 2026 /PRNewswire/ -- American Healthcare REIT, Inc. (the "Company") (NYSE: AHR) announced today that it will issue its fourth quarter 2025 earnings release on Thursday, February 26, 2026, after the close of trading.
U.S. equity markets stumbled to close out the year, while long-term interest rates swelled toward four-month highs, as investors digested resilient economic data and locked in gains from 2025 leaders. The tranquil holiday season was jolted by dramatic geopolitical developments over the weekend, after a U.S. military operation captured and extradited Venezuelan strongman Nicolás Maduro. The stunningly bold strike furthered an ongoing hemispheric realignment, and at minimum, shifted control of the world's largest known oil reserves away from China and Russia toward the United States.
American Healthcare REIT, Inc. (NYSE: AHR - Get Free Report) Director Jeffrey Hanson sold 19,208 shares of the firm's stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average price of $48.40, for a total value of $929,667.20. The sale was disclosed in a document filed with the SEC, which is
American Healthcare REIT, Inc. (NYSE: AHR - Get Free Report) Director Jeffrey Hanson sold 35,570 shares of the company's stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $48.38, for a total transaction of $1,720,876.60. Following the sale, the director directly owned 19,208 shares of the company's stock,
American Healthcare REIT (NYSE: AHR - Get Free Report) and American Tower (NYSE: AMT - Get Free Report) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Volatility and Risk American Healthcare REIT has
Orion Porfolio Solutions LLC raised its holdings in shares of American Healthcare REIT, Inc. (NYSE: AHR) by 101.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 30,057 shares of the company's stock after purchasing an additional 15,128 shares
American Healthcare REIT is rated a hold, reaffirming my prior 2 hold ratings. This is contrarian to the bullish consensus of Wall Street and some analysts recently. AHR's strengths come from a growing portfolio and future pipeline, macro demand for senior care and outpatient medical, FFO growth, and modest leverage risk vs. peers. Consider this stock has a limited dividend growth history since 2024 and is trading at a 3x premium to book value, with some technical chart indicators also showing a hold pattern.
U.S. equity markets posted mixed performance as surprisingly cool inflation data and soft employment data were tempered by a hawkish pushback from Fed officials and skeptics clinging to inflation fears. The critical CPI report showed inflation easing to four-year lows, a heavily criticized report that may, ironically, be the most accurate inflation reading in several years due to collection limitations. The report "zeroed out" shelter inflation due to incomplete collection, combined with an antiquated and lagged sampling methodology, effectively "correcting" its data by removing the most persistent source of distortion.
Osaic Holdings Inc. lowered its position in shares of American Healthcare REIT, Inc. (NYSE: AHR) by 4.1% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 259,649 shares of the company's stock after selling 11,073 shares during the quarter.
California-based Global IMC exited a stake in American Healthcare REIT during the third quarter. The firm sold 222,038 shares, reducing the position value by $8.16 million.
Some end-of-year Big Picture thoughts, including on the demographic destiny of falling population growth and the headwinds to economic growth that come with it. Why tariff-driven inflation is unlikely to generate anything more than a short-term bump followed by continued disinflation. Why the huge amount of cash on the sidelines could progressively become a tailwind to other types of financial assets, including dividend-paying stocks.
American Healthcare REIT (AHR) offers the most attractive pure-play exposure to the senior housing megatrend, outperforming even data center REITs recently. Senior housing fundamentals are exceptionally strong, with surging 80+ demographics and historically low new supply, driving occupancy and rent growth. AHR trades at a more reasonable valuation than Welltower (WELL), with similar double-digit FFO growth forecasts but a higher yield and improving balance sheet.
IRVINE, Calif. , Dec. 18, 2025 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) ("AHR", the "Company", "it", and "our") announced today that it has closed over $950 million of new acquisitions year-to-date in 2025 with no further acquisitions expected to close between now and year-end.
Here is how American Healthcare REIT (AHR) and KeyCorp (KEY) have performed compared to their sector so far this year.
IRVINE, Calif. , Dec. 16, 2025 /PRNewswire/ -- American Healthcare REIT, Inc. (NYSE: AHR) announced today that its board of directors has declared a quarterly distribution of $0.25 per share for the quarter ending December 31, 2025.
REITs endured a brutal three-plus-year stretch since March 2022, underperforming the S&P 500 by an unprecedented 70 percentage points, far worse than the Global Financial Crisis. Extreme underperformance has left REITs historically cheap despite solid property-level fundamentals, but this valuation discount carries a cost: elevated capital costs, suppressed transaction activity, and limited external growth opportunities. Depressed public-market valuations have triggered a pronounced “REIT exodus,” with 40 REITs acquired, liquidated, or seeking sales since 2022, while new REIT formation has collapsed to a fraction of norms.
I plan to diversify my REIT-heavy portfolio by systematically allocating to four dividend-focused ETFs in 2026. US economic growth remains steady but subdued, while equity valuations are elevated, suggesting muted long-term returns. REITs appear attractively valued with fading headwinds, offering plausible outperformance as fundamentals improve and rate cuts loom.
The REIT sector returned to positive territory in November (+1.02%) after back-to-back months in the red. Mid caps (+3.53%) led the REIT sector in November followed by small caps (+3.38%) and large caps (+0.32%); micro caps (-8.76%) badly underperformed. 68.15% of REIT securities had a positive total return in November.